Teligent (TLGT) Stock Price, News & Analysis

Company Overview

Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. It also provides contract manufacturing services to the pharmaceutical, over-the-counter, and cosmetic markets. The company was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.01 to $0.05
• 52-Week Range: N/A
• Volume: 6,460 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TLGT Stock Analysis - Frequently Asked Questions

How were Teligent's earnings last quarter?

Teligent, Inc. (NASDAQ:TLGT) posted its quarterly earnings data on Monday, August, 16th. The company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.13) by $0.01. The firm earned $10.43 million during the quarter.

When did Teligent's stock split?

Teligent shares reverse split on Thursday, May 28th 2020.The 1-10 reverse split was announced on Wednesday, May 27th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Teligent own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Teligent investors own include Meta Platforms (META), Novavax (NVAX), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), TherapeuticsMD (TXMD), AbbVie (ABBV) and Alphabet (GOOG).

Company Calendar

• Last Earnings: 8/16/2021
• Today: 6/24/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED-GENERIC DRG
• Sub-Industry: N/A
• Current Symbol: NASDAQ:TLGT
• CIK: 352998
• Web: www.teligent.com
• Phone: (856) 697-1441
• Fax: 856-697-1442
• Employees: 2,357
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Optionable
• Beta: N/A